The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 13, 2022

Filed:

Mar. 02, 2018
Applicant:

Bayer Aktiengesellschaft, Leverkusen, DE;

Inventors:

Simone Romoli, Great Shelford, GB;

Tobias Bauch, Wuppertal, DE;

Karoline Dröbner, Velbert, DE;

Assignee:

BAYER AKTIENGESELLSCHAFT, Leverkusen, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 49/00 (2006.01); G01N 33/50 (2006.01); G01N 33/68 (2006.01); G01N 33/70 (2006.01);
U.S. Cl.
CPC ...
A61K 49/0008 (2013.01); G01N 33/5008 (2013.01); G01N 33/6827 (2013.01); G01N 33/70 (2013.01); G01N 2500/00 (2013.01); G01N 2800/347 (2013.01);
Abstract

The present invention is related to short-term renal injury models and methods for creating these models. The models and methods can be used for identifying, testing or characterizing candidate molecules with respect to their suitability to treat renal injury. The methods comprise a step of inducing, in a test subject, renal injury by administering subcutaneously a bolus of a renal injury inducer, in a dosage sufficiently high to induce renal injury. Different types of readout for renal injury are provided such as albumin creatinine ratio (ACR) determined in a urine sample taken from the subject, or the development of transcutaneous fluorescence after injection of a fluorescent molecule. Based on the readout the degree of renal injury and/or alteration of GFR can be determined.


Find Patent Forward Citations

Loading…